Home › NDC Lookup › Ingredients › Benzethonium Chloride › 60762-0113-08
🧴image loading
(from DailyMed)

CA-REZZ - NORISC - INCONTINENT WASH BENZETHONIUM CHLORIDE .12 g/100mL Solution, 237 mL — NDC 60762-113-08 (Billing 60762-0113-08)

by FNC MEDICAL CORPORATION · 237 mL in 1 BOTTLE, SPRAY

This is a package of 237 mL of CA-REZZ - NORISC - INCONTINENT WASH BENZETHONIUM CHLORIDE .12 g/100mL Solution from FNC MEDICAL CORPORATION, marketed since Feb 2018 and currently FDA-listed. It is this product's only package size.

NDC 60762-0113-08
🏷️ FDA NDC (as labeled) 60762-113-08 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 60762-113-08 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
60762 labeler · 113 product · 08 package
Package marketed since
Feb 5, 2018
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
237 mL per package
Barcode (UPC-A, from the NDC)
3 6076211308 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 60762-113-08
Product NDC 60762-113
11-digit billing NDC 60762011308
NCPDP billing unit ML — per mL (volume)
RxCUI 1876355, 1876392
UNII PH41D05744
Application # M003
SPL Set ID ed26fa74-5ae8-4294-b61d-682d6ad4b32a
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-02-05
Route TOPICAL
Dosage form SOLUTION
Substance BENZETHONIUM CHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90971550000900
GPI class Ca-Rezz Norisc
GCN Seq No 077204
GCN 43151
HICL code 004259
Ingredient (HICL) Benzethonium Chloride
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5B
Therapeutic class — specific (HIC3) Topical Preparations,Antibacterials
AHFS code 84:04.92.00
AHFS class Local Anti-Infectives, Miscellaneous
FDB label name CA-REZZ NORISC WASH
FDB brand name Ca-Rezz Norisc
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 077204
  • GCN: 43151
  • GPI-14 (Medi-Span): 90971550000900
  • HICL (First Databank): 004259
  • AHFS class code: 84:04.92.00
  • RxCUI (RxNorm): 1876355
Why two NDCs? The FDA registers this code as 60762-113-08 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 60762-0113-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiseptics class.

Drug family (ATC) Antiseptics, Quaternary ammonium compounds
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name CA-REZZ NORISC WASH Ingredient Benzethonium Chloride
🧪 What is this product?

CA-REZZ NORISC is a topical solution wash containing benzethonium chloride, an antimicrobial ingredient. This OTC monograph product is typically used to cleanse and help prevent bacterial growth on skin, commonly applied in settings where incontinence care is needed. Benzethonium chloride functions as an antimicrobial agent intended to reduce odor and maintain skin hygiene in affected areas.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
60762-0113-08 You're viewing this Main listing 237 mL in 1 BOTTLE, SPRAY 2018-02-05 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
TriDerma Pressure Sore Relief .0012 g/g 10738-0031-88 Genuine 243 g — — FDA listed —
TriDerma Clean Soothe Bottom Wash .0012 g/g 10738-0096-88 Genuine 243 g — — FDA listed —
Ca-Rezz - Norisc - Incontinent Wash .12 g/100mLthis 60762-0113-08 FNC 237 ml — — FDA listed —
Ca-Rezz - Long Term Care - Incontinent Cleanser .12 g/100mL 60762-0151-16 FNC 474 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2018
On the market since
Feb 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII SNN716810P
    A waxy substance derived from lanolin, an oil from sheep's wool, that has been chemically modified. It acts as an emulsifier and thickener to help blend water and oil-based ingredients together and improve texture.
  • UNII KIZ4X2EHYX
    A plant extract from the aloe vera leaf, used in medicines as a moisturizing agent and skin-conditioning ingredient. It helps soften and soothe the product's texture in topical formulations.
  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII 4Q43814HXS
    Cetyl acetate is a waxy compound made by combining cetyl alcohol with acetic acid. It works as a binder and thickener in medicines, helping to hold ingredients together and give the product a smooth, creamy texture.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII 18L9G3U51M
    A gentle cleansing agent derived from coconut oil. It acts as a surfactant and emulsifier, helping mix oil and water-based ingredients together and improve how the product spreads or cleanses on skin.
  • UNII 147D247K3P
    Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII 6OZP39ZG8H
    Polysorbate 80 is a synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together in medications and improves how the product disperses in the body.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII BPV390UAP0
    Sodium laureth sulfate is a mild detergent and surfactant derived from coconut oil or petroleum. It helps mix oil and water in formulations and is often used as a cleaning or foaming agent in topical products like shampoos and cleansers.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

12 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesDEIONIZED WATER, SODIUM LAURETH SULFATE, PROPYLENE GLYCOL, DISODIUM COCOAMPHODIACETATE, POLYSORBATE 80 (AND) CETYL ALCOHOL (AND) ACETYLATED LANOLIN ALCOHOL, ALOE VERA EXTRACT, CITRIC ACID, PHENOXYETHANOL, ETHYHEXYLGLYCERIN, D&C YELLOW #10, FRAGRANCE.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerFNC MEDICAL CORPORATION
FDA applicationM003 (OTC MONOGRAPH DRUG)
Labeler code60762
First marketedFeb 2018
Product typeHuman Otc Drug
Portfolio3 products on file

More NDCs from FNC MEDICAL CORPORATION labeler code 60762

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 46 words ▾

USES CA-REZZ NORSIC WASH HAS BEEN FORMULATED AS AN INCONTINENT WASH TO QUICKLY EMULSIFY BODY WASTE EVEN IN THE MOST SENSITIVE PERINEAL AREAS. CA-REZZ NORSIC WASH IS PH BALANCED AND ENRICHED WITH ALOE VERA, TO SOOTHE AND HELP PROMOTE HEALING OF FRAGILE, IRRITATED SKIN. STOPS ODORS.

⏱️ Dosage and Administration 71 words ▾

DIRECTIONS SPRAY CA-REZZ NORSIC WASH WHERE URINE, FECES OR EMESIS HAS SOILED SKIN PAD LINENS AND CLOTHING. REMOVE BULK OF FECES OR EMESIS. SPRAY ADDITIONAL CA-REZZ NORSIC WASH ON WARM WET CLOTH. CLEANSE SKIN OF ALL REMAINING RESIDUE. PAT DRY. NOTE: IF AREA NEEDING CARE IS SIZEABLE AND FECAL OR EMESIS MATERIAL MASSIVE, RINSING IS ADVISED. ADD ONE CAPFUL OF CA-REZZ NORSIC WASH TO THE REGULAR LAUNDRY TO ELIMINATE RESIDUAL ODORS.

⚠️ Warnings 18 words ▾

WARNINGS FOR EXTERNAL USE ONLY. IF RASH OR IRRITATION DEVELOP, DISCONTINUE USE. CONSULT A PHYSICIAN IF IRRITATION PERSISTS.

🧪 Active Ingredient 5 words ▾

ACTIVE INGREDIENT BENZETHONIUM CHLORIDE 0.12%

🧪 Inactive Ingredients 30 words ▾

INGREDIENTS DEIONIZED WATER, SODIUM LAURETH SULFATE, PROPYLENE GLYCOL, DISODIUM COCOAMPHODIACETATE, POLYSORBATE 80 (AND) CETYL ALCOHOL (AND) ACETYLATED LANOLIN ALCOHOL, ALOE VERA EXTRACT, CITRIC ACID, PHENOXYETHANOL, ETHYHEXYLGLYCERIN, D&C YELLOW #10, FRAGRANCE.

🎯 Purpose 2 words ▾

PURPOSE ANTIBACTERIAL

📄 Keep Out of Reach of Children 6 words ▾

KEEP OUT OF REACH OF CHILDREN.

📄 Other Information 9 words ▾

OTHER INFORMATION CA-REZZ NORSIC WASH IS ENRICHED WITH ALOE.

📄 Questions or Comments 6 words ▾

QUESTIONS OR COMMENTS? PLEASE CALL 1-800-440-2888

📄 Package Label / Principal Display Panel 2 words ▾

Incontinent Wash_8oz_LBL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for CA-REZZ - NORISC - INCONTINENT WASH (this brand).

Top reported reactions

Nausea23
Hypersensitivity20
Headache18
Therapeutic Product Effect Decreased17
Contraindicated Product Administered10
Diarrhoea6
Death5

Reporter sex

85 reports
Male · 38%
Female · 62%
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 12 2
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by FNC MEDICAL CORPORATION. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
FNC MEDICAL CORPORATION is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 60762-0112-04 · FNC 60762-0151-16 · FNC →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.